SEP 21, 2017 5:43 AM PDT

Permanent Birth Control Coil Pulled From Non-US Markets

WRITTEN BY: Xuan Pham

Essure coil | Image credit: Bayer

Women living outside the US will no longer have the option to get the sterilization device Essure, as Bayer is withdrawing this product from all countries except the US. Per Bayer, the decision was driven by commercial reasons. However, others speculate the decision may be tied to the increasing number of women who have reported health problems related to the implanted device.

Essure is a form of permanent birth control (female sterilization). The device consists of a flexible metal coil that’s inserted into the woman’s fallopian tubes. There, the coil intentionally triggers inflammation. And as the body heals over the next several months, new scar tissues will form around the coil, which create a barrier that prevents the sperm from meeting the eggs. The permanent birth control method is also known as hysteroscopic sterilization. Women who elect to have the Essure implant must fully understand its permanence; that is, the device isn’t intended to be removed.

But the device has been linked to a number of cases of severe pain and other adverse reactions. One woman reported the device caused such severe pain that she was suicidal.

"The device was sold to me as a simple and easy procedure. I was told that I'd be in and out of the doctor's office in 10 minutes and that there'd be no recovery time,” recalled Laura Linkson, who received the device in 2013 in England. "I went from being a mum who was doing everything with her children, to a mum that was stuck in bed unable to move without pain, at some points being suicidal. I felt like I was a burden on everyone around me.”

Others have reported reactions to the nickel and plastic that make up the device. Even worse, device is capable of perforating through the fallopian tube and embedding itself elsewhere in the body.

The only recourse to correct these issues is drastic: removal of the device, which includes the woman’s fallopian tubes, and in some cases, her uterus too.

Bayer maintains their decision to pull the device is purely strategic. "We would like to reassure the Essure patients and their accompanying healthcare professionals that this decision is made for commercial reasons and that it is not related to a safety or product quality issue," the company said in a statement on its website.

Nevertheless, the US Food and Drug Administration (FDA) is keeping close tabs on Essure. "The FDA has taken several steps to ensure the ongoing evaluation of Essure's safety and efficacy, as well as to educate healthcare professionals and women about the potential risks of using the device," said a spokeswoman for the FDA.

Additional sources: BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 28, 2020
Drug Discovery & Development
FDA Approves 5-Minute Coronavirus Test
MAR 28, 2020
FDA Approves 5-Minute Coronavirus Test
In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change th ...
MAR 29, 2020
Genetics & Genomics
Biomarkers That Predict Crohn's Disease Are Identified
MAR 29, 2020
Biomarkers That Predict Crohn's Disease Are Identified
A series of studies published in Gastroenterology has outlined new approaches in predicting IBD.
MAY 23, 2020
Microbiology
The FDA Yanks Some COVID-19 Antibody Tests From the Market
MAY 23, 2020
The FDA Yanks Some COVID-19 Antibody Tests From the Market
The massive demand for diagnostic testing led the FDA to open a short window for many testing products to go to market w ...
JUN 07, 2020
Genetics & Genomics
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
JUN 07, 2020
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
When children have a rare genetic disease and do not have access to whole-genome sequencing and the analysis it requires ...
JUL 27, 2020
Cancer
Identifying Tumor Cells in the Blood with Artificial Intelligence
JUL 27, 2020
Identifying Tumor Cells in the Blood with Artificial Intelligence
Cancer diagnostics is an area of keen interest in the fight against cancer. Cancer often slips by routine checkups and v ...
JUL 30, 2020
Genetics & Genomics
How Are DNA Testing Companies Helping the Fight Against COVID?
JUL 30, 2020
How Are DNA Testing Companies Helping the Fight Against COVID?
One of the most puzzling characteristics of coronavirus is how some people develop severe symptoms and die from the dise ...
Loading Comments...